lobbying_activities: 2348951

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2348951	bdad1fd6-14dc-472f-b536-abc9acf89ba7	Q3	FORGE FEDERAL AFFAIRS LLC	400865535	LILLY USA LLC	2019	third_quarter	PHA	Opposition to prescription drug importation and cuts to Medicare Part D funding. Support for funding of Department of Homeland Security drug interdiction efforts. Issues related to pricing of prescription drugs. Monitoring H.R.3, Lower Drug Costs Now Act of 2019 and S.2543, Prescription Drug Pricing Reduction Act of 2019.	HOUSE OF REPRESENTATIVES	20000		0	0	2019-10-17T22:53:12.433000-04:00